A Randomised Feasibility Study of EPA and Cox-2 Inhibitor (Celebrex) Versus EPA, Cox-2 Inhibitor (Celebrex), Resistance Training Followed by Ingestion of Essential Amino Acids High in Leucine in NSCLC Cachectic Patients - ACCeRT Study

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-11-493
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Inducible COX-2 Dominates Over COX-1 in Prostacyclin Biosynthesis: Mechanisms of COX-2 Inhibitor Risk to Heart Disease

Life Sciences
GeneticsMolecular BiologyPharmacologyBiochemistryMedicineToxicologyPharmaceutics
2011English

Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in Osteoarthritis

Archives of Internal Medicine
2000English

Selective COX-2 Inhibitor (Meloxicam) and Tooth-Supporting Bone Quality. A Histomorphometric Study in Rats

Brazilian Dental Journal
Dentistry
2017English

Novel COX-2 Inhibitor for Breast Cancer Therapy

2003English

COX-1 and COX-2 Products in the Gut: Therapeutic Impact of COX-2 Inhibitors

Gut
Gastroenterology
2000English

Scaffold of the Cyclooxygenase-2 (COX-2) Inhibitor Carprofen Provides Alzheimer G-Secretase Modulators

English

Arachidonic Acid Oxygenation by COX-1 and COX-2

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1999English

COX-1 and COX-2 in Health and Disease

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1999English

Combination COX-2 Inhibitor and Metformin Attenuate Rate of Joint Replacement in Osteoarthritis With Diabetes: A Nationwide, Retrospective, Matched-Cohort Study in Taiwan

PLoS ONE
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy